Home › Funds › Goldman Sachs Group › BEAM
Goldman Sachs Group position in BEAM
BEAM THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.31M sh
Reported value held$44.96M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.04M | $90.85M | New |
| Q4 2021 | 974.02K | $77.62M | Reduce |
| Q1 2022 | 829.25K | $47.52M | Reduce |
| Q2 2022 | 953.93K | $36.93M | Add |
| Q3 2022 | 1.05M | $50.10M | Add |
| Q4 2022 | 1.02M | $39.83M | Reduce |
| Q1 2023 | 658.26K | $20.16M | Reduce |
| Q2 2023 | 726.02K | $23.18M | Add |
| Q3 2023 | 461.72K | $11.10M | Reduce |
| Q4 2023 | 484.15K | $13.18M | Add |
| Q1 2024 | 552.21K | $18.25M | Add |
| Q2 2024 | 784.56K | $18.38M | Add |
| Q3 2024 | 680.85K | $16.68M | Reduce |
| Q4 2024 | 719.86K | $17.85M | Add |
| Q1 2025 | 677.16K | $13.22M | Reduce |
| Q2 2025 | 1.28M | $21.83M | Add |
| Q3 2025 | 1.32M | $32.00M | Add |
| Q4 2025 | 522.64K | $14.49M | Reduce |
| Q1 2026 | 1.01M | $23.97M | Add |
| Q2 2026 | 1.31M | $44.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BEAM
- Fidelity Management & Research (FMR) 12.61M sh · $432.74M · Q2 2026
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- BlackRock Inc 9.00M sh · $308.80M · Q2 2026
- Vanguard Group 9.19M sh · $254.84M · Q4 2025
- Geode Capital Management 2.60M sh · $89.14M · Q2 2026
- Morgan Stanley 1.95M sh · $66.96M · Q2 2026
- Two Sigma Investments 1.39M sh · $47.64M · Q2 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Northern Trust Corp 933.48K sh · $32.04M · Q2 2026
- Charles Schwab Investment Management 885.90K sh · $30.40M · Q2 2026